AstraZeneca (Switzerland) to move to Quadrolith complex

The British Swedish pharmaceutical company AstraZeneca has announced its Swiss subsidiary is to move from its premises in Greifenau in the city of Zug into the Quadrolith office complex next year, where some 120 staff will be employed .
 
The pharmaceutical company has signed a tenancy agreement with the Baar-based property company Alfred Müller to rent an area of 2,800 square metres in this new building, a computer-generated image of which can be seen in the photograph. The property company has also been commissioned to design the interior of the space rented.
 
The staff currently working from the premises in Greifenau will be moving to these new premises in Baar, possibly on 1 July 2018 or even earlier, and joined by other staff working in international roles, bringing the total employed there, as mentioned, to 120. However, Cambridge in the United Kingdom will remain the listed company’s worldwide headquarters, as spokeswoman Kristin Breuer explained. “We need more space and would like to work on a more flexible basis, and this will be possible at the Quadrolith,” she said, while adding that the firm had not specifically chosen the municipality of Baar as its new location, but these premises provided all they wanted.
 
Speaking in her capacity of managing director of the Swiss subsidiary, Biljana Naumovic said the company was looking forward to its move to Baar. Last year AstraZeneca, which employs 50,000 worldwide, achieved a turnover of $23 billion.
 
Christoph Müller, the chairman of the board of the property company, said he was very pleased to have been able to attract AstraZeneca to the Quadrolith building, adding that 95% of the first stage of the complex had been let, and this, five months before its completion. He further added that work was on schedule and that it was expected the façade would be completed by the end of this year.